Your browser doesn't support javascript.
loading
Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM.
McKinney, Andrew; Lindberg, Olle R; Engler, Jane R; Chen, Katharine Y; Kumar, Anupam; Gong, Henry; Lu, Kan V; Simonds, Erin F; Cloughesy, Timothy F; Liau, Linda M; Prados, Michael; Bollen, Andrew W; Berger, Mitchel S; Shieh, Joseph T C; James, C David; Nicolaides, Theodore P; Yong, William H; Lai, Albert; Hegi, Monika E; Weiss, William A; Phillips, Joanna J.
Afiliação
  • McKinney A; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • Lindberg OR; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • Engler JR; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • Chen KY; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • Kumar A; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • Gong H; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • Lu KV; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • Simonds EF; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • Cloughesy TF; Department of Neurology, University of California, San Francisco, San Francisco, California.
  • Liau LM; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
  • Prados M; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
  • Bollen AW; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
  • Berger MS; Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
  • Shieh JTC; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • James CD; Department of Pathology, Division of Neuropathology, University of California, San Francisco, San Francisco, California.
  • Nicolaides TP; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • Yong WH; Division of Medical Genetics, Department of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco, San Francisco, California.
  • Lai A; Institute for Human Genetics, University of California, San Francisco, San Francisco, California.
  • Hegi ME; Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Weiss WA; Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.
  • Phillips JJ; Department of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco, San Francisco, California.
Mol Cancer Ther ; 18(9): 1565-1576, 2019 09.
Article em En | MEDLINE | ID: mdl-31270152
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Resistencia a Medicamentos Antineoplásicos / Ensaios Antitumorais Modelo de Xenoenxerto / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Resistencia a Medicamentos Antineoplásicos / Ensaios Antitumorais Modelo de Xenoenxerto / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2019 Tipo de documento: Article